生物標誌物市場：按產品類型、應用、適應症（癌症、心血管疾病、神經系統疾病、傳染病等）、最終用戶、地區 - 規模、份額、前景、機會分析，2022~2030 年

生物標誌物是指示生物狀態或狀況的定量標誌物。 血液、尿液和軟組織通常用於測試和研究生物標誌物，以研究典型的生物過程、致病過程或對治療干預的藥理學反應。 生物標誌物用於許多科學領域。 生物標誌物有兩種類型：生物標誌物檢測試劑盒和生物標誌物分析儀。 按臨床用途組織的一套相對較新的臨床工具包括醫療行業中使用的生物標誌物。

市場動態

預計市場參與者推出更多產品將推動預測期內的市場增長。 例如，2021 年 4 月 19 日，利用科學和創新將新穎概念和醫學發現轉化為治療危及生命疾病患者的治療方法的全球生物技術公司安進公司宣布推出轉移性生物標誌物援助計劃，旨在為急性（IV 期）非小細胞肺癌 (NSCLC) 患者提供生物標誌物檢測。 確定患者適當治療的一個重要初始步驟是診斷時的生物標誌物測試。 Biomarker Assist 允許符合條件的患者獲得生物標記測試的折扣。

此外，2022 年 2 月 28 日，美國國立衛生研究院 (FNIH) 生物標誌物聯盟將宣布最有效的血液測試，以評估對早期發現罕見神經退行性疾□□病很重要的蛋白質。啟動一項旨在尋找測試的倡議計劃。 神經絲作為家族性額葉變性 (FTD) 中神經變性的流體生物標誌物 這項名為“神經絲作為家族性額葉變性 (FTD) 中神經變性的流體生物標誌物”的研究發現，對這種稱為神經絲的蛋白質進行的一項或多項血液測試可以用於識別額葉退化的遺傳和家族聯繫。我們計劃證明我們可以識別有風險的個體 (FTD)。 這是朝著開發一種可靠、廉價、無創的方法以更準確地預測額葉變性 (FTD) 邁出的重要的第一步。 此外，那些感到受到威脅的人可以參與新規格的臨床研究，最終將導致治療的發展。

這項研究的主要特點

• 本報告對全球生物標誌物市場進行了深入分析，顯示了以 2021 年為基準年的預測期（2022-2030 年）的市場規模（十億美元）和復合年增長率 (CAGR%)。它提供。
• 它還闡明了不同細分市場的潛在創收機會，並描述了該市場具有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數介紹全球生物標誌物市場主要參與者的概況。
• 本研究涵蓋的主要公司包括 Agilent Technologies, Inc.、F. Hoffmann-La Roche Ltd.、Acobiom、Apis Assay Technologies Ltd.、Eagle Biosciences, Inc.、Beckman Coulter, Inc.、PerkinElmer Inc.、Biopanda Reagents Ltd, Quanterix, Secure Diagnostics Pvt. Ltd., BioVision Inc., Merck KGaA, R&D Systems, Life Diagnostics, QuantaMatrix Inc., Nanjing Synthgene Medical Technology Co., Ltd, LifeSpan BioSciences, Inc., Wako USA, BioLegend, Inc. ., Abnova Corporation 和 Abbexa
• 這份報告中的見解應該能讓企業營銷人員和管理人員就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。看來。
• 《全球生物標誌物市場報告》面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球生物標誌物市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第2章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按產品類型劃分的市場概況
  • 市場概況：按應用分類
  • 市場概況：按疾病適應症分類
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 商機
• 影響分析
• 主要發展狀況
• 行業趨勢
• 監管場景
• 最近的產品批准/發布
• 害蟲分析
• 搬運工分析

第 4 章全球生物標誌物市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 對需求的影響
• 對醫療保健的影響
• 流行病學

第 5 章全球生物標誌物市場：按類型，2017-2030

• 生物標誌物測試
• 生物標誌物分析儀

第 6 章全球生物標誌物市場：按應用分類，2017-2030

• 診斷生物標誌物
• 用於監測的生物標誌物
• 藥物發現和藥物開發
• 預測性生物標誌物
• 預後生物標誌物

第 7 章全球生物標誌物市場：按疾病適應症分類，2017-2030

• 癌症
• 心血管疾病
• 神經系統疾病
• 感染
• 其他（免疫性疾病、自身免疫性疾病等）

第 8 章全球生物標誌物市場：最終用戶，2017-2030

• 2022 年和 2030 年各地區的市場份額分析 (%)
• 2017-2030 年按地區劃分的同比增長分析
• 各地區的趨勢
• 醫院
  • 2017-2030 年市場規模、預測、同比增長率
• 研究所
  • 2017-2030 年市場規模和預測，同比增長率
• 診斷實驗室
  • 2017-2030 年市場規模和預測，同比增長率
• 研究和學術機構
  • 2017-2030 年市場規模、預測、同比增長率

第 9 章全球生物標誌物市場：按地區劃分，2017-2030

• 北美
• 美國（美國）
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 德國
• 英國
• 法國
• 意大利
• 西班牙
• 俄羅斯
• 其他歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 澳大利亞
• 韓國
• 東盟
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 南非
• 中非
• 北非

第10章競爭格局

• 熱圖分析
• 市場份額分析
  • Agilent Technologies, Inc.
  • F.Hoffmann-La Roche Ltd.
  • Acobiom
  • Apis Assay Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer Inc.
  • Biopanda Reagents Ltd
  • Quanterix
  • Secure Diagnostics Pvt. Ltd.
  • BioVision Inc.
  • Merck KGaA
  • R&D Systems
  • Life Diagnostics
  • QuantaMatrix Inc.
  • Nanjing Synthgene Medical Technology Co., Ltd
  • LifeSpan BioSciences, Inc.
  • Wako USA
  • BioLegend, Inc.
  • Abnova Corporation
  • Abbexa

第 11 章章節

• 調查方法介紹
• 關於出版商

A biomarker is a quantifiable sign of a biological condition or state. In order to investigate typical biological processes, pathogenic processes, or pharmacologic reactions to a therapeutic intervention, biomarkers are frequently examined and studied utilizing blood, urine, or soft tissues. Numerous scientific disciplines employ biomarkers. There are 2 types of biomarkers actively used in the market, they are Biomarker test Kits and Biomarker Analyzer. A relatively new set of clinical toolsets organized by clinical applications includes biomarkers utilized in the medical industry.

Market Dynamics

Increasing product launch by market players is expected to drive the market growth over the forecast period. For instance, on April 19, 2021, Amgen Inc., a global biotechnology company that uses science and innovation to translate novel concepts and medical discoveries into treatments for patients with life-threatening illnesses, announced the launch of the Biomarker Assist program, which aims to provide access to biomarker testing for patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker Assist.

Furthermore, on February 28, 2022, an initiative program was launched by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium aims to find the most effective blood tests for assessing a protein that is crucial for the early detection of rare neurodegenerative illnesses. The "Neurofilament as a Fluid Biomarker of Neuro degeneration in Familial Front temporal Degeneration (FTD)" study will demonstrate that one or more blood tests for this protein, known as neurofilament, can be used to determine individuals at risk of Front temporal Degeneration (FTD) due to genetic and familial ties. This is a crucial first step in developing a trustworthy, affordable, and non-invasive method to more accurately predict Front temporal Degeneration (FTD). Also, those who are at threat can take part in clinical studies of novel specifics, eventually leading to the development of treatments.

Key features of the study:

• This report provides an in-depth analysis of the global biomarkers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
• Key companies covered as a part of this study include Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Acobiom, Apis Assay Technologies Ltd., Eagle Biosciences, Inc., Beckman Coulter, Inc., PerkinElmer Inc., Biopanda Reagents Ltd, Quanterix, Secure Diagnostics Pvt. Ltd., BioVision Inc., Merck KGaA, R&D Systems, Life Diagnostics, QuantaMatrix Inc., Nanjing Synthgene Medical Technology Co., Ltd, LifeSpan BioSciences, Inc., Wako USA, BioLegend, Inc., Abnova Corporation, and Abbexa
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global biomarkers market

Detailed Segmentation:

• Global Biomarkers Market, By Product Type:
  • Biomarker Test Kits
  • Biomarker Analyzer
• Global Biomarkers Market, By Application:
  • Diagnostic Biomarkers
  • Monitoring Biomarkers
  • Drug Discovery And Development
  • Predictive Biomarkers
  • Prognostic Biomarkers
• Global Biomarkers Market, By Disease Indication
  • Cancer
  • Cardiovascular Disease
  • Neurological Disorder
  • Infectious disease
  • Others (Immunological Disorder, and Autoimmune Disorders among others )
• Global Biomarkers Market, By End User:
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Research and Academic Institute
• Global Biomarkers market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Agilent Technologies, Inc. *
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • F.Hoffmann-La Roche Ltd.
  • Acobiom
  • Apis Assay Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer Inc.
  • Biopanda Reagents Ltd
  • Quanterix
  • Secure Diagnostics Pvt. Ltd.
  • BioVision Inc.
  • Merck KGaA
  • R&D Systems
  • Life Diagnostics
  • QuantaMatrix Inc.
  • Nanjing Synthgene Medical Technology Co. Ltd
  • LifeSpan BioSciences Inc
  • Wako USA,
  • BioLegend, Inc
  • Abnova Corporation
  • Abbexa

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
• Impact Analysis
• Key Developments
• Industry Trends
• Regulatory Scenario
• Recent Product Approval/Launches
• PEST Analysis
• Porter's Analysis

4. Global Biomarkers Market- Impact of Coronavirus (COVID-19) Pandemic

• Impact on Demand
• Impact on Healthcare
• Epidemiology

5. Global Biomarkers Market, By Type, 2017 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biomarker Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Biomarker Analyzers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

6. Global Biomarkers Market, By Application, 2017 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Diagnostic Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Monitoring Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Drug discovery and development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Predictive Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Prognostic Biomarkers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

7. Global Biomarkers Market, By Disease Indication, 2017 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Cardiovascular Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Neurological Disorder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Bn)
• Infectious disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Others (Immunological Disorder, and Autoimmune Disorders among others )
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

8. Global Biomarkers Market, End User, 2017 - 2030 (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030(%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
  • Regional Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017- 2030, (US$ Bn)
• Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017- 2030, (US$ Bn)
• Research and Academic Institute
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Bn)

9. Global Biomarker Market, By Region, 2017 - 2030 (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030(%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
  • Regional Trends
• North America
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• U.S.
• Canada
• Latin America
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Market Size and Forecast, By Type, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Application, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Bn)
  • Market Size and Forecast, By End User, 2017 - 2030 (US$ Bn)
• South Africa
• Central Africa
• North Africa

10. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • F.Hoffmann-La Roche Ltd.
  • Acobiom
  • Apis Assay Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer Inc.
  • Biopanda Reagents Ltd
  • Quanterix
  • Secure Diagnostics Pvt. Ltd.
  • BioVision Inc.
  • Merck KGaA
  • R&D Systems
  • Life Diagnostics
  • QuantaMatrix Inc.
  • Nanjing Synthgene Medical Technology Co., Ltd
  • LifeSpan BioSciences, Inc.
  • Wako USA
  • BioLegend, Inc.
  • Abnova Corporation
  • Abbexa
• Analyst Views

11. Section

• Research Methodology
• About Us